Eidos Therapeutics
AcquiredATTR-CM Condition Research & Scientific Insights – BridgeBio
San Francisco, United States · Founded 2016 · $91.0M raised
- Headquarters
- San Francisco, California
- Employees
- 11–50
- Founded
- 2016
- Business Model
- B2B
- Website
- eidostx.com
- Total Funding
- $91.0M
- Last Round
- $64.0M Series BApr 2018
- Rounds
- 2
- Acquisition Date
- Jan 2021
About
Clinical-stage biopharmaceutical company developing therapies for transthyretin amyloidosis.
Summary
Eidos Therapeutics is a Biotech company based in San Francisco, United States, founded in 2016. It has raised $91.0M in total across 2 rounds, most recently a $64.0M Series B round in Apr 2018. Investors include BridgeBio, RA Capital Management and Viking Global.
Tech & App Stack
7 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jan 2021
Sign up to see all 4 rounds
Series A through Acquisition — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/eidos-therapeutics"><img src="https://indexed.vc/api/badge/company/eidos-therapeutics" alt="Eidos Therapeutics on Indexed.vc" width="260" height="76" /></a>